No benefit from high-dose multivitamins seen for HIV patients receiving antiretroviral therapy
A new study by Harvard School of Public Health (HSPH) researchers suggests that, for HIV patients receiving highly active antiretroviral therapy (HAART) to treat HIV, there is no benefit from high- vs. standard-dose micronutrient ...
Oct 16, 2012